Reversal of haloperidol-induced extrapyramidal side effects in Cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers

Neuropsychopharmacology

Volumn 18, Issue 5, 1998, Pages 399-402

  Christoffersen, Curt L ^a   Meltzer, Leonard T ^a  

^a PFIZER INC   (United States)

Author keywords

Cebus monkey; Dopamine antagonists; Dystonias; Extrapyramidal side effects; Haloperidol; Serotonin 1(A)

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; APOMORPHINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CEBIDAE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; ENANTIOMER; EXTRAPYRAMIDAL SYMPTOM; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTI-DYSKINESIA AGENTS; ANTIPSYCHOTIC AGENTS; APOMORPHINE; BASAL GANGLIA DISEASES; CEBUS; FEMALE; HALOPERIDOL; MALE; SEROTONIN AGONISTS; STEREOISOMERISM; TIME FACTORS;

EID: 0031937466     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00176-0     Document Type: Article

References (15)

1. Ahlenius S, Hillegaart V, Wijkstrom A Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat. Naunyn-Schmiedeberg's Arch Pharmacol. 339:1989;551-556.
2. Ahlenius S, Hillegaart V, Wijkstrom A Increased dopamine turnover in the ventral striatum by 8-OH-DPAT administration in the rat. J Pharm Pharmacol. 42:1990;285-288.
3. Arvidsson LE, Hacksell U, Nilsson JLG, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H 8-Hydroxy-2-(alkylamino)tetralin, new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem. 24:1981;921-923.
4. Cornfield LJ, Lambert G, Arvidsson L-E, Mellin C, Vallgarda J, Hacksell U, Nelson DL Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine 1A receptors that are negatively coupled to adenylate cyclase. Mol Pharmacol. 39:1991;780-787.
5. Downs DA, Harrigan SE, Heffner TG Buspirone effects in a primate model of extrapyramidal dysfunction. Soc Neurosci Abstr. 11:1985;426.
6. 1A receptors coupled to adenylyl cyclase are a model for the postsynaptic receptors in the rat hippocampus. Br J Pharmacol. 107:1992;141-145.
7. Hjorth S, Carlsson A Buspirone. Effects on central monoaminergic transmission - possible relevance to animal experimental and clinical findings Eur J Pharmacol. 83:1982;299-303.
8. 1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Neuropharmacology. 27:1988;515-518.
9. 1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. J Pharmacol Exp Ther. 280:1997;1241-1249.
10. 2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys. No evidence for reciprocal 5-HT-dopamine interaction Psychopharmacology. 97:1989;456-461.
11. McMillen BA, Metthews RT, Sanghera MK, Shepard PD, German DC Dopamine receptor antagonism by the novel anti-anxiety drug, buspirone. J Neurosci. 3:1983;733-738.
12. Meltzer HY Role of serotonin in the action of atypical antipsychotic drugs. Clin Neurosci. 3:1995;64-75.
13. Meltzer LT, Christoffersen CL, Serpa KA, Pugsley TA, Razmpour A, Heffner TG Lack of involvement of haloperidol-sensitive sigma binding sites in modulation of dopamine neuronal activity and induction of dystonias by antipsychotic drugs. Neuropharmacology. 9:1992;961-967.
14. Skirboll LR, Grace AA, Bunney BS Dopamine auto- and postsynaptic receptors. Electrophysiological evidence for differential sensitivity to dopamine agonists Science. 206:1979;80-82.
15. Wadenberg ML, Ahlenius S Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat. Enhancement of antipsychotic-like effects without catalepsy J Neural Trans [GenSect]. 83:1991;43-53.